Selank is a peptide studied in anxiety and brain-function research. Symptom scores and brain-imaging findings need to be interpreted in the context of each study's size and design.
What the research shows
A 2008 study compared Selank with medazepam in 62 patients. A 2020 study examined functional connectivity in healthy volunteers receiving Selank, Semax or placebo. Imaging findings do not establish universal anxiety-treatment or concentration benefits. [1] [2]
Distinguishing substances and products
Selank and Semax are different substances even when examined within one study. Similar names or shared product categories do not make their evidence interchangeable.
Reading a specific brand’s label
Start with the exact substance and product name, then match the label to the manufacturer’s documents. This article does not establish Thai registration or current availability for an unspecified product.
Frequently asked questions
Is Selank the same as Semax?
No. They are different substances requiring matching evidence.
Do imaging changes prove clinical benefit?
Not by themselves. Clinical outcomes must match the claim.
What information helps identify a specific product?
The brand, product name, full label and matching manufacturer documents. Evidence about the substance alone does not establish a product’s identity, registration or quality.
Related information
For general questions about names or label details, contact LINE: @musclestationth
Sources and review date
- Zozulia et al., 2008 — Selank clinical comparison
- Panikratova et al., 2020 — functional connectivity study
Sources checked: 11 September 2026. This page explains selected primary sources; it is not a systematic review of every study.